| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Second Regular National Report on the Implementation of the Cartagena Protocol on Biosafety
Record information and status
Record ID
102488
Status
Published
Date of creation
2011-10-07 19:05 UTC (andrew.bowers@cbd.int)
Date of last update
2011-11-08 20:00 UTC (andrew.bowers@cbd.int)
Date of publication
2011-11-08 20:00 UTC (andrew.bowers@cbd.int)

This document is also available in the following languages:
Origin of report
Country
  • Burkina Faso
Contact officer for report
Coordinates
Prof. Chantal Y. ZOUNGRANA / KABORÉ
Directrice
Agence Nationale de Biosécurité (ANB)
01 BP 5933
Ouagadougou 01
Burkina Faso
Phone:+226 50 37 88 54
Email:cykabore@yahoo.fr
Consulted stakeholders
9. Organizations/stakeholders who were consulted or participated in the preparation of this report
FR
Comité scientifique de biosécurité, Observatoire national de biosécurité, différents ministères (Recherche, Enseignements, Santé, Environnement, Agriculture, Justice, Ressources Animales, Commerce,coopération internationale), sociétés cotonnières, associations de producteurs, de femmes, de jeune, communicateurs, Société civile.
Submission
10. Date of submission
2011-09-28
11. Time period covered by this report
Start date
2007-09
Time period covered by this report
End date
2011-09
Party to the Cartagena Protocol on Biosafety
12. Is your country a Party to the Cartagena Protocol on Biosafety (CPB)?
  • Yes
Article 2 – General provisions
15. Has your country introduced the necessary legal, administrative and other measures for the implementation of the Protocol?
  • A domestic regulatory framework is fully in place
16. Which specific instruments are in place for the implementation of your national biosafety framework?
  • One or more national biosafety laws
  • One or more national biosafety regulations
  • Other laws, regulations or guidelines that indirectly apply to biosafety
17. Has your country established a mechanism for the budgetary allocations of funds for the operation of its national biosafety framework?
  • Yes
18. Does your country have permanent staff to administer functions directly related to the national biosafety framework?
  • Yes
19. If you answered Yes to question 18, how many permanent staff members are in place whose functions are directly related to the national biosafety framework?
  • More than 10
20. Has your country’s biosafety framework / laws / regulations / guidelines been submitted to the Biosafety Clearing-House (BCH)?
  • Partially
21. Here you may provide further details on the implementation of Article 2 in your country:
FR
Mesures administratives: Cadre National de Biosécurité en 2004; l'Autorité nationale compétente: Agence Nationale de Biosécurité (ANB) en 2005; le Comité Scientifique Nationale de Biosécurité (CSNB) en 2006; l'Observatoire National de Biosécurité (ONB) en 2008

Mesures juridiques : Règles Nationales en Matière de Sécurité en Biotechnologies en 2004;

Loi no005-2006/AN portant régime de sécurité en matière de Biotechnologie au Burkina Faso

Autres : Politique Nationale Forestière; Politique Nationale de Polutation, et autres politiques de développement durable
Article 5 – Pharmaceuticals
22. Does your country regulate the transboundary movement, handling and use of living modified organisms (LMOs) which are pharmaceuticals?
  • Yes
23. If you answered Yes to question 22, has this information been submitted to the BCH?
  • No
24. Here you may provide further details on the implementation of Article 5 in your country:
FR
Il n'ya pas de traitement spécifique pour les produits pharmaceutiques qui sont des OGM; ils sont traités de la même façon que tout autre produit pharmaceutique.
Article 6 – Transit and Contained use
25. Does your country regulate the transit of LMOs?
  • Yes
26. Does your country regulate the contained use of LMOs?
  • Yes
27. If you answered Yes to questions 25 or 26, has this information been submitted to the BCH?
  • No
28. Here you may provide further details on the implementation of Article 6 in your country:
FR
Le transit des OGM suit la même procédure que l'importation. Le milieu confiné est aussi réglementé par la loi portant régime de sécurité en Biotechnologie au Burkina Faso
Articles 7 to 10 – Advance Informed Agreement (AIA) and intentional introduction of LMOs into the environment
29. Has your country adopted law(s) / regulations / administrative measures for the operation of the AIA procedure of the Protocol?
  • Yes
30. Has your country adopted a domestic regulatory framework consistent with the Protocol regarding the transboundary movement of LMOs for intentional introduction into the environment?
  • Yes
31. Has your country established a mechanism for taking decisions regarding first intentional transboundary movements of LMOs for intentional introduction into the environment?
  • Yes
32. If you answered Yes to question 31, does the mechanism also apply to cases of intentional introduction of LMOs into the environment that were not subject to transboundary movement?
  • Yes
33. Has your country established a mechanism for monitoring potential effects of LMOs that are released into the environment?
  • Yes
34. Does your country have the capacity to detect and identify LMOs?
  • Yes, to some extent
35. Has your country established legal requirements for exporters under its jurisdiction to notify in writing the competent national authority of the Party of import prior to the intentional transboundary movement of an LMO that falls within the scope of the AIA procedure?
  • Yes
36. Has your country established legal requirements for the accuracy of information contained in the notification?
  • Yes
37. Has your country ever received an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • Yes
38. Has your country ever taken a decision on an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • Yes
39. If you answered Yes to question 38, how many LMOs has your country approved to date for import for intentional introduction into the environment?
  • Less than 5
40. If you answered Yes to question 38, how many LMOs, not imported, has your country approved to date for intentional introduction into the environment?
  • None
41. In the current reporting period, how many applications/notifications has your country received regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • More than 10
42. In the current reporting period, how many decisions has your country taken regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • More than 10
43. With reference to the decisions taken on intentional transboundary movements of LMOs for intentional introduction into the environment, has your country received a notification from the Party(ies) of export or from the exporter(s) prior to the transboundary movement?
  • Yes, always
44. Did the notifications contain complete information (at a minimum the information specified in Annex I of the Cartagena Protocol on Biosafety)?
  • Yes, always
45. Has your country acknowledged receipt of the notifications to the notifier within ninety days of receipt?
  • Yes, always
46. Has your country informed the notifier(s) and the BCH of its decision(s)?
  • In some cases only
47. Has your country informed the notifier(s) and the BCH of its decision(s) in due time (within 270 days or the period specified in your communication to the notifier)?
  • Yes, always
48. What percentage of your country’s decisions fall into the following categories?
  • Approval of the import/use of the LMO(s) with conditions
100%
49. In cases where your country approved an import with conditions or prohibited an import, did it provide reasons on which its decisions were based to the notifier and the BCH?
  • In some cases only
50. Here you may provide further details on the implementation of Articles 7-10 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs for intentional introduction to the environment:
FR
A la différence du Protocole de Cartagena, l'Accord Préalable en Connaissance de Cause dans la loi du Burkina s'applique aussi au transit et au milieu confiné.

Concernant la question 34 sur l'existence de capacités de détection et d'identification des OVM, les compétences humaines existent pour la détection des OGM. Il existe également des laboratoires dans les quels l'identification de certains OVM est possible. Cependant, tout le système sera performant quand on aura finit de mettre en place le laboratoire national de Biosécurité qui a une vocation régionale. Le processus de mise en place de ce laboratoire est en cours.

Par rapport à la question 46 et à la question 49, nous avons toujours informé l'auteur de la demande mais pas le centre d'échange sur la prévention des risques biotechnologiques.
Article 11 – Procedure for living modified organisms intended for direct use as food or feed, or for processing (LMOs-FFP)
51. Has your country adopted specific law(s) or regulation(s) for decision-making regarding domestic use, including placing on the market, of LMOs-FFP?
  • Yes
52. Has your country established legal requirements for the accuracy of information to be provided by the applicant?
  • Yes
53. Has your country established a mechanism to ensure that decisions regarding LMOs-FFP that may be subject to transboundary movement will be communicated to the Parties through the BCH?
  • Yes
54. Has your country established a mechanism for taking decisions on the import of LMOs-FFP?
  • Yes
55. Has your country declared through the BCH that in the absence of a regulatory framework its decisions prior to the first import of an LMO-FFP will be taken according to Article 11.6 of the Cartagena Protocol on Biosafety?
  • No
56. Has your country indicated its needs for financial and technical assistance and capacity building in respect of LMOs-FFP?
  • No
57. Has your country ever taken a decision on LMOs-FFP (either on import or domestic use)?
  • No
63. Here you may provide further details on the implementation of Article 11 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs-FFP:
FR
La loi du Burkina ne traite pas de façon spécifique la question des OGM destinés à être utilisés directement dans l'alimentation humaine ou animale ou à être transformés
Article 12 – Review of decision
64. Has your country established a mechanism for the review and change of a decision regarding an intentional transboundary movement of LMOs?
  • No
65. Has your country ever received a request for a review of a decision?
  • No
66. Has your country ever reviewed / changed a decision regarding an intentional transboundary movement of LMOs?
  • No
67. In the current reporting period, how many decisions were reviewed and/or changed regarding an intentional transboundary movement of an LMO?
  • None
71. Here you may provide further details on the implementation of Article 12 in your country:
FR
Il n'existe pas un mécanisme de reconsidération d'un dossier de demande; au besoin, il faut toujours introduire une nouvelle demande.
Article 13 – Simplified procedure
72. Has your country established a system for the application of the simplified procedure regarding an intentional transboundary movement of LMOs?
  • No
73. Has your country ever applied the simplified procedure?
  • No
75. In the current reporting period, how many LMOs has your country applied the simplified procedure to?
  • None
76. Here you may provide further details on the implementation of Article 13 in your country:
FR
La règlementation nationale sur les OGM ne prévoient pas de procédure simplifiée.
Article 14 – Bilateral, regional and multilateral agreements and arrangements
77. Has your country entered into any bilateral, regional or multilateral agreements or arrangements?
  • No
80. Here you may provide further details on the implementation of Article 14 in your country:
FR
Le Burkina Faso est impliqué dans l'élaboration d'une réglementation régionale qui est en cours avec l'UEMOA, la CEDEAO et le CILSS.
Article 15 – Risk assessment
81. Has your country established a mechanism for conducting risk assessments prior to taking decisions regarding LMOs?
  • Yes
82. If you answered Yes to question 81, does this mechanism include procedures for identifying experts to conduct the risk assessments?
  • Yes
83. Has your country established guidelines for how to conduct risk assessments prior to taking decisions regarding LMOs?
  • Yes
84. Has your country acquired the necessary domestic capacity to conduct risk assessment?
  • Yes
85. Has your country established a mechanism for training national experts to conduct risk assessments?
  • Yes
86. Has your country ever conducted a risk assessment of an LMO for intentional introduction into the environment?
  • Yes
87. Has your country ever conducted a risk assessment of an LMO intended for direct use as food or feed, or for processing?
  • No
88. If your country has taken decision(s) on LMOs for intentional introduction into the environment or on domestic use of LMOs-FFP, were risk assessments conducted for all decisions taken?
  • Yes, always
89. Has your country submitted summary reports of the risk assessments to the BCH?
  • In some cases only
90. In the current reporting period, if your country has taken decisions regarding LMOs, how many risk assessments were conducted in the context of these decisions?
  • Less than 10
91. Has your country ever required the exporter to conduct the risk assessment(s)?
  • No
92. Has your country ever required the notifier to bear the cost of the risk assessment(s) of LMOs?
  • Yes, always
93. Here you may provide further details on the implementation of Article 15 in your country:
FR
Par rapport à l'évaluation des risques, les ressources humaines existent mais il faut les renforcer de même que le dispositif matériel.
Article 16 – Risk management
94. Has your country established and maintained appropriate and operational mechanisms, measures and strategies to regulate, manage and control risks identified in risk assessments for:
94.1) LMOs for intentional introduction into the environment?
  • Yes
94.2) LMOs intended for direct use as food or feed, or for processing?
  • No
95. Has your country established and maintained appropriate measures to prevent unintentional transboundary movements of LMOs?
  • Yes
96. Has your country taken measures to ensure that any LMO, whether imported or locally developed, undergoes an appropriate period of observation that is commensurate with its life-cycle or generation time before it is put to its intended use?
  • Yes
97. Has your country cooperated with other Parties with a view to identifying LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • No
98. Has your country cooperated with other Parties with a view to taking measures regarding the treatment of LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • No
99. Here you may provide further details on the implementation of Article 16 in your country, including any details regarding risk management strategies, also in case of lack of scientific certainty on potential adverse effects of LMOs:
FR
Selon la loi Burkinabè, l'utilisateur, avant toute utilisation d'OGM, a la responsabilité de proposer des mesures de gestion des risques proportionnels aux risques réels et potentiels inhérents à l'utilisation et à la dissémination dudit OGM. Ces mesures doivent être validées.
Article 17 – Unintentional transboundary movements and emergency measures
100. Has your country made available to the BCH the relevant details setting out its point of contact for the purposes of receiving notifications under Article 17?
  • Yes
101. Has your country established a mechanism for addressing emergency measures in case of unintentional transboundary movements of LMOs that are likely to have significant adverse effect on biological diversity?
  • Yes
102. Has your country implemented emergency measures in response to information about releases that led, or may have led, to unintentional transboundary movements of LMOs?
  • No
103. In the current reporting period, how many times has your country received information concerning occurrences that led, or may have led, to unintentional transboundary movement(s) of one or more LMOs to or from territories under its jurisdiction?
  • Never
107. Here you may provide further details on the implementation of Article 17 in your country:
FR
Dans le cas du Burkina, des plans d'intervention d'urgence sont prévus avant tout mouvement transfrontière pour gérer les éventuels accidents
Article 18 – Handling, transport, packaging and identification
108. Has your country taken measures to require that LMOs that are subject to transboundary movement are handled, packaged and transported under conditions of safety, taking into account relevant international rules and standards?
  • Yes
109. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is not known through means such as identity preservation systems, they may contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • Yes
110. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is known through means such as identity preservation systems, they contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • Yes
111. Has your country taken measures to require that documentation accompanying LMOs that are destined for contained use clearly identifies them as living modified organisms and specifies any requirements for the safe handling, storage, transport and use, the contact point for further information, including the name and address of the individual and institution to whom the LMO are consigned?
  • Yes
112. Has your country taken measures to require that documentation accompanying LMOs that are intended for intentional introduction into the environment of the Party of import, clearly identifies them as living modified organisms; specifies the identity and relevant traits and/or characteristics, any requirements for the safe handling, storage, transport and use, the contact point for further information and, as appropriate, the name and address of the importer and exporter; and contains a declaration that the movement is in conformity with the requirements of this Protocol applicable to the exporter?
  • Yes
113. Does your country have the capacity to enforce the requirements of identification and documentation of LMOs?
  • Yes, to some extent
114. Has your country established procedures for the sampling and detection of LMOs?
  • Yes, to some extent
115. Here you may provide further details on the implementation of Article 18 in your country:
FR
Des mesures adéquates doivent être prises par l'utilisateur en matière de transport afin d'éviter toute dissémination dans l'environnement.

Tout OGM destiné à la commercialisation ou à la diffusion dans l'environnement doit être emballé et étiquetté de manière indélébile et infalcifiable avec la mention "produits à base d'OGM" ou "contient des OGM".

Toute manipulation doit faire l'objet d'une autorisation préalable de l'autorité compétente.
Article 19 – Competent National Authorities and National Focal Points
116. Has your country designated one national focal point for the Cartagena Protocol to be responsible for liaison with the Secretariat?
  • Yes
117. Has your country designated one national focal point for the Biosafety Clearing-House to liaise with the Secretariat regarding issues of relevance to the development and implementation of the BCH?
  • Yes
118. Has your country designated one or more competent national authorities, which are responsible for performing the administrative functions required by the Cartagena Protocol on Biosafety and are authorized to act on your country’s behalf with respect to those functions?
  • Yes, one
120. Has your country made available the required information referred in questions 116-119 to the BCH?
  • Yes, all information
122. Has your country established adequate institutional capacity to enable the competent national authority(ies) to perform the administrative functions required by the Cartagena Protocol on Biosafety?
  • Yes
Article 20 – Information Sharing and the Biosafety Clearing-House (BCH)
124. Please provide an overview of the status of the information provided by your country to the BCH by specifying for each category of information whether it is available and whether it has been submitted to the BCH.
124.a) Existing national legislation, regulations and guidelines for implementing the Protocol, as well as information required by Parties for the advance informed agreement procedure (Article 20, paragraph 3 (a))
  • Information available but only partially available in the BCH
124.b) National laws, regulations and guidelines applicable to the import of LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 5)
  • Information available but not in the BCH
124.c) Bilateral, multilateral and regional agreements and arrangements (Articles 14, paragraph 2 and 20, paragraph 3 (b))
  • Information not available
124.d) Contact details for competent national authorities (Article 19, paragraphs 2 and 3), national focal points (Article 19, paragraphs 1 and 3), and emergency contacts (Article 17, paragraph 3 (e))
  • Information available and in the BCH
124.e) Reports submitted by the Parties on the operation of the Protocol (Article 20, paragraph 3 (e))
  • Information available but not in the BCH
124.f) Decisions by a Party on regulating the transit of specific living modified organisms (LMOs) (Article 6, paragraph 1)
  • Information not available
124.g) Occurrence of unintentional transboundary movements that are likely to have significant adverse effects on biological diversity (Article 17, paragraph 1)
  • Information not available
124.h) Illegal transboundary movements of LMOs (Article 25, paragraph 3)
  • Information not available
124.i) Final decisions regarding the importation or release of LMOs (i.e. approval or prohibition, any conditions, requests for further information, extensions granted, reasons for decision) (Articles 10, paragraph 3 and 20, paragraph 3(d))
  • Information available but not in the BCH
124.j) Information on the application of domestic regulations to specific imports of LMOs (Article 14, paragraph 4)
  • Information not available
124.k) Final decisions regarding the domestic use of LMOs that may be subject to transboundary movement for direct use as food or feed, or for processing (Article 11, paragraph 1)
  • Information not available
124.l) Final decisions regarding the import of LMOs intended for direct use as food or feed, or for processing that are taken under domestic regulatory frameworks (Article 11, paragraph 4) or in accordance with annex III (Article 11, paragraph 6) (requirement of Article 20, paragraph 3(d))
  • Information not available
124.m) Declarations regarding the framework to be used for LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 6)
  • Information not available
124.n) Review and change of decisions regarding intentional transboundary movements of LMOs (Article 12, paragraph 1)
  • Information not available
124.o) LMOs granted exemption status by each Party (Article 13, paragraph 1)
  • Information not available
124.p) Cases where intentional transboundary movement may take place at the same time as the movement is notified to the Party of import (Article 13, paragraph 1)
  • Information not available
124.q) Summaries of risk assessments or environmental reviews of LMOs generated by regulatory processes and relevant information regarding products thereof (Article 20, paragraph 3 (c))
  • Information available but not in the BCH
125. Has your country established a mechanism for strengthening the capacity of the BCH National Focal Point to perform its administrative functions?
  • No
126. Has your country established a mechanism for the coordination among the BCH National Focal Point, the Cartagena Protocol focal point, and the competent national authority(ies) for making information available to the BCH?
  • No
127. Does your country use the information available in the BCH in its decision making processes on LMOs?
  • Yes, in some cases
128. Has your country experienced difficulties accessing or using the BCH?
  • No
129. If you answered Yes to question 128, has your country reported these problems to the BCH or the Secretariat?
  • Not applicable
130. Is the information submitted by your country to the BCH complete and up-to date?
  • No
131. Here you may provide further details on the implementation of Article 20 in your country:
FR
Le point des informations à poster a été effectué et des dispositions sont prises pour s'acquiter au mieux de cette obligation.
Article 21 – Confidential information
132. Has your country established procedures to protect confidential information received under the Protocol?
  • Yes
133. Does your country allow the notifier to identify information that is to be treated as confidential?
  • Yes, always
134. Here you may provide further details on the implementation of Article 21 in your country:
FR
La possibilité est donnée à l'auteur de la notification d'indiquer les informations confidentielles et lorsque ces dernières sont réellement jugées telles quelles, obligation est faite de les traiter en conséquence.
Article 22 – Capacity-building
135. Has your country received external support or benefited from collaborative activities with other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
136. If you answered Yes to question 135, how were these resources made available?
  • Bilateral channels
137. Has your country provided support to other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
138. If you answered Yes to question 137, how were these resources made available?
  • Regional channels
139. Is your country eligible to receive funding from the Global Environment Facility (GEF)?
  • Yes
140. Has your country ever initiated a process to access GEF funds for building capacity in biosafety?
  • Yes
141. If you answered Yes to question 140, how would you characterize the process?
Please add further details about your experience in accessing GEF funds under question 150.
  • Very difficult
142. Has your country ever received funding from the GEF for building capacity in biosafety?
  • Development of national biosafety frameworks
  • Building Capacity for Effective Participation in the BCH (Phase I)
  • Building Capacity for Effective Participation in the BCH (Phase II)
143. During the current reporting period, has your country undertaken activities for the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
144. If you answered Yes to question 143, in which of the following areas were these activities undertaken?
  • Institutional capacity
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Public awareness, participation and education in biosafety
  • Scientific, technical and institutional collaboration at subregional, regional and international levels
  • Identification of LMOs, including their detection
  • Formation de divers acteurs sur le contenu de la loi portant régime de sécurité en matière de Biotechnologie au Burkina Faso
145. During the current reporting period, has your country carried out a capacity-building needs assessment?
  • Yes
146. Does your country still have capacity-building needs?
  • Yes
147. If you answered Yes to question 146, indicate which of the following areas still need capacity-building.
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Technology transfer
  • Identification of LMOs, including their detection
  • Socio-economic considerations
  • Implementation of the documentation requirements under Article 18.2 of the Protocol
  • Measures to address unintentional and/or illegal transboundary movements of LMOs
  • Taking into account risks to human health
148. Has your country developed a capacity-building strategy or action plan?
  • No
149. Has your country submitted the details of national biosafety experts to the Roster of Experts in the BCH?
  • No
150. Here you may provide further details on the implementation of Article 22 in your country, including further details about your experience in accessing GEF funds:
FR
Le processus d'obtention du fonds FEM est très difficile; c'est un processus très long. Le caneva est difficile à remplir, la soumission se fait seulement au cours de deux sessions dans l'année et avec beaucoup de risques de reprise. Il y'a aussi l'exigence de cofinancement qui est assez élevé. Aussi, tous les documents doivent être soumis en anglais et à la charge du demandeur. Par ailleurs, du fait qu'il y ait une enveloppe globale pour financer toutes les activités sans une répartition par composante (exemple Biosécurité) ne facilite pas l'acquisition des fonds au niveau national.
Article 23 – Public awareness and participation
151. Has your country established a strategy or put in place legislation for promoting and facilitating public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes
152. Has your country established a biosafety website?
  • No
153. Has your country established a mechanism to ensure public access to information on living modified organisms that may be imported?
  • Yes, to a limited extent
154. Has your country established a mechanism to consult the public in the decision-making process regarding LMOs?
  • Yes, to a limited extent
155. Has your country established a mechanism to make available to the public the results of decisions taken on LMOs?
  • Yes
156. Has your country taken any initiative to inform its public about the means of public access to the Biosafety Clearing-House?
  • Yes
157. In the current reporting period, has your country promoted and facilitated public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes
158. If you answered Yes to question 157, has your country cooperated with other States and international bodies?
  • No
159. In the current reporting period, how many times has your country consulted the public in the decision-making process regarding LMOs and made the results of such decisions available to the public?
  • None
160. Here you may provide further details on the implementation of Article 23 in your country:
FR
L'information du public se fait par voie de presse (conférence, radio, télévision, journaux) chaque fois qu'une décision est prise concernant les OGM.

Par rapport à la participation du public, la loi prévoit cette disposition mais sa mise en œuvre est assez complexe.

Dès que cela est possible, l'adresse du CEPRB est communiquée au public (exemple sur les dépliants et lors des séances de sensibilisation du public)
Article 24 – Non-Parties
161. Has your country entered into any bilateral, regional, or multilateral agreement with non-Parties regarding transboundary movements of LMOs?
  • No
162. Has your country ever imported LMOs from a non-Party?
  • Yes
163. Has your country ever exported LMOs to a non-Party?
  • No
164. If you answered Yes to questions 162 or 163, were the transboundary movements of LMOs consistent with the objective of the Cartagena Protocol on Biosafety?
  • Yes, always
165. If you answered Yes to questions 162 or 163, was information about these transboundary movements submitted to the BCH?
  • No
166. If your country is not a Party to the Cartagena Protocol, has it contributed information to the BCH on LMOs released in, or moved into, or out of, areas within its national jurisdiction?
  • Not applicable
Article 25 – Illegal transboundary movements
168. Has your country adopted domestic measures aimed at preventing and/or penalizing transboundary movements of LMOs carried out in contravention of its domestic measures to implement this Protocol?
  • Yes
169. Has your country established a strategy for detecting illegal transboundary movements of LMOs?
  • Yes
170. In the current reporting period, how many times has your country received information concerning cases of illegal transboundary movements of an LMO to or from territories under its jurisdiction?
  • Never
175. Here you may provide further details on the implementation of Article 25 in your country:
FR
Pour la prévention des mouvements transfrontières illicites, les agents des frontières (douaniers, agents phytosanitaires, agents des eaux et forêts) sont pris en compte dans un programme national de formation théorique et d'utilisation pratique de kits de détection.

Par ailleurs, la repression est prévue par des sanctions énoncées dans la loi.
Article 26 – Socio-economic considerations
176. If your country has taken a decision on import, has it ever taken into account socio-economic considerations arising from the impact of the LMO on the conservation and sustainable use of biological diversity?
  • Yes
177. Has your country cooperated with other Parties on research and information exchange on any socio-economic impacts of LMOs?
  • No
178. Here you may provide further details on the implementation of Article 26 in your country:
FR
Dans le cas de la loi du Burkina, les considérations socio-économiques sont beaucoup plus larges dans la prise de décision. La loi dispose que l'autorité nationale compétente ne peut délivrer une autorisation que si elle établie que l'OGM:

- profite au pays sans causer de risque dommageable pour la santé humaine, animale, la diversité biologique et l'environnement;

- participe au développement durable;

- ne nuit pas à l'environnement socio-économique;
Article 27 – Liability and Redress
179. Has your country signed the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress?
  • No
180. Has your country initiated steps towards ratification, acceptance or approval of the Nagoya-Kuala Lumpur Supplementary Protocol?
  • Yes
181. Here you may provide further details on any activities undertaken in your country towards the implementation of the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress:
FR
Le processus est en cours
Article 33 – Monitoring and reporting
182. Has your country submitted the previous national reports (Interim and First National Reports)?
  • No
183. If your country did not submit previous reports, indicate the main challenges that hindered the submission
  • Difficulty in compiling the information from various sectors
Other information
184. Please use this field to provide any other information on issues related to national implementation of the Protocol, including any obstacles or impediments encountered.
FR
Re: Q. 14 - Le Burkina Faso a signé le protocole le 24 Mai 2000 et l'a ratifié le 04 Août 2003. Le protocole est entré en vigueur au Burkina Faso le 02 Novembre 2003

Re: Q. 135 - Des formations ont été reçues dans les domaines suivants: Evaluation et gestion des risques; Formulation du problème et analyse du risque; Essais au champ en milieu confiné; Communication du risque, Inspection; Utilisation du BCH.

Re: Q. 136 - Voies Régionales aussi

Re: Q. 137 - Le Burkina Faso a été solicité plusieurs fois au niveau de certaines rencontres bilatérales ou regionales pour partager son expérience en matière de Biosécurité.

Re: Q. 138 - Voies Multilatérales aussi
Comments on reporting format
185. Please use this field to provide any other information on difficulties that you have encountered in filling in this report.
FR
Pour certaines questions, deux aspects sont souvent concernés en même temps alors que la réalisation de l'un n'implique pas obligatoirement celle de l'autre. Exemple: la réalisation d'une activité et son postage au niveau du CEPRB (question 46 et autres)
Survey on indicators of the Strategic Plan (2014)
In decision BS-VI/15, Parties requested the Executive Secretary to conduct a dedicated survey to gather information corresponding to indicators in the Strategic Plan that could not be obtained from the second national reports or through other existing mechanisms.

The answers to the survey are displayed below.
When did your national biosafety framework become operational?
indicator 1.1.1
  • 2006
Here you may provide further details
FR
un credit a été contracté par l'Etat pour la mise en place d'un laboratoire de contrôle des OGM et pour des activités:  renforcement des capacités juridique et institutionnelle et du personnel en charge de la biosécurité; information et sensibilisation du public; suivi de l'application des règles de biosécurité. L'utilisation de ces fonds a commencé en 2009 et doit finir en 2013.
Survey 4. How many biosafety short-term training programmes and/or academic courses are offered annually in your country?
indicator 1.2.3
  • 5 per year or more
Here you may provide further details
FR
Des modules de formations ont été dispensés dans des universités(université polytechnique de Bobo-dioulasso(UPB) et Université de Ouagadougou(UO). par ailleurs des formations de courtes durées à l'atention des scientifiques, des regulateurs, des agents des frontières, de la société civile ont été organisées.
Survey 5. Does your country have in place a functional national mechanism for coordinating biosafety capacity-building initiatives?
indicator 1.2.4
  • Yes
Here you may provide further details
FR
l'Agence a été désignée comme autorité nationale compétente en matière de biosécurité. pour cela elle a un programme de renforcement des capacités, et elle colabore avec l'Université polytechnique de bobo pour definir certaines formations de courtes durées.   Par ailleurs elle est impliquée dans un programme de capacité avec certaines organisations régionales et internationales telles que l'union économique et monnetaire Ouest africain (UEMOA) et centre international pour le génie génétique et la biotechnologie (ICGEB)
Survey 6. How much additional funding (in the equivalent of US dollars) has your country mobilized in the last four years to support implementation of the Biosafety Protocol, beyond the regular national budgetary allocation?
indicator 1.2.5
  • 1,000,000 USD or more
Survey 7. Does your country have predictable and reliable funding for building capacity for the effective implementation of the Protocol?
indicator 1.2.6
  • Yes
Here you may provide further details
FR
les fonds spécifiques qui ont été alloués pour le renforcement des capacités couvrent la periode 2009-2013.
Survey 8. How many LMO-related collaborative bilateral/multilateral arrangements has your country established with other Parties/non-Parties?
indicator 1.2.8
  • None
Survey 9. Has your country adopted or used any guidance documents for the purpose of conducting risk assessment and/or risk management?
indicator 1.3.1.1
Survey 9.a) Risk assessment
  • Yes
Survey 9.b) Risk management
  • Yes
Here you may provide further details
FR
le comité scientifique qui est l'organe chargé d'évaluer les dossiers de demande d'autorisation utilise un formulaire et des lignes directrices pour l'évaluation des risques et la gestion des risques.
Survey 10. Has your country adopted or used any guidance documents for the purpose of evaluating risk assessment reports submitted by notifiers?
indicator 1.3.1.2
  • Yes
Here you may provide further details
FR
le comité scientifique national de biosécurité peut s'appuyer sur les rapports d'évaluation des risques soumis par les notifiants pour effectuer sa propre évaluation des risques.
Survey 11. Has your country adopted any common approaches to risk assessment with other countries?
indicator 1.3.2
  • No
Here you may provide further details
FR
Une initiative régionale des pays de l'UEMOA visant à mettre en place des méthodes communes d'évaluation des risques est en cours.
Survey 12. Has your country ever conducted a risk assessment of an LMO?
indicator 1.3.3
  • Yes
Here you may provide further details
FR
Plusieurs évaluations des risques ont été conduites pour des OGM en milieu confiné et pour la commercialisation.
Survey 13. Does your country have the capacity to identify, assess and/or monitor living modified organisms or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity, taking into account risks to human health?
indicator 1.4.2
Survey 13.a) Identify
  • Yes
Survey 13.b) Assess
  • Yes
Survey 13.c) Monitor
  • Yes
Here you may provide further details
FR
Il existe des laboratoires capable d'identifier, de controler les OGM qui peuvent avoir un effet défavorable. Cependant des besoins de renforcement des capacités du personnel sont souhaités de même que du renforcement en matériels est souhaité.
Survey 14. Does your country have available any guidance for the purpose of ensuring the safe handling, transport, and packaging of living modified organisms?
indicator 1.6.4
  • No
Survey 15. Does your country have any specific approaches or requirements that facilitate how socio-economic considerations should be taken into account in LMO decision making?
indicator 1.7.2
  • No
Survey 16. How many peer-reviewed published materials has your country used for the purpose of elaborating or determining national actions with regard to socio-economic considerations?
indicator 1.7.1
  • None
Survey 17. What is your country's experience, if any, in taking socio-economic considerations into account in LMO decision making?
indicator 1.7.3
FR
Les considérations socio-economiques interviennent dans la prise de décision lors de l'octroi de l'autorisation pour la commercialisation.
Survey 18. Does your country have the capacity to take appropriate measures in the event that an LMO is unintentionally released?
indicator 1.8.3
  • Yes
Here you may provide further details
FR
La loi prévoit le mécanisme a utiliser lorsque la detection d'un OVM libéré de façon non intentionnel surviendrait.  De même lors de l'octroi d'une autorisation, il est exigé la description de mesures d'urgences a mettre en place dans une telle situation.
Survey 19. How many people in your country have been trained in risk assessment, monitoring, management and control of LMOs?
indicator 2.2.3
Survey 19.a) Risk assessment
  • 10 or more
Survey 19.b) Monitoring
  • 10 or more
Survey 19.c) Management / Control
  • 10 or more
Here you may provide further details
FR
Des formations sur l'évaluation et la gestion des risques ont été réalisées au profit des membres du cadre national de biosécurité. aussi, une formation sur les procédures d'inspection et de controle des OGM  a été réalisée.  D'autres formations ont été déroulées sur la règlementation nationale en matière d'OGM. Dans ce cas, plus de cent (100) personnes ont été formées.
Survey 20. Does your country have the infrastructure (e.g. laboratory facilities) for monitoring or managing LMOs?
indicator 2.2.4
  • No
Survey 21. Is your country using training material and/or technical guidance for training in risk assessment and risk management of LMOs?
indicator 2.2.5
  • No
Survey 22. Are the available training materials and technical guidance on risk assessment and risk management of LMOs sufficient and effective?
indicator 2.2.6
Survey 22.a) Sufficient
  • Yes
Survey 22.b) Effective
  • Yes
Survey 23. How many customs officers in your country have received training in the identification of LMOs?
indicator 2.3.1
  • None
Here you may provide further details
FR
Des formations sur la détection des OGM sont prevues avec les douaniers.
Survey 24. How many laboratory personnel in your country have received training in detection of LMOs?
indicator 2.3.1
  • One or more
Here you may provide further details
FR
Au niveau du personnel de la recheche et des universités, des spécialistes en biotechnologie sachant détecter des OVM existent sans qu'une quantification n'ait été faite.
Survey 25. Does your country have reliable access to laboratory facilities for the detection of LMOs?
indicator 2.3.2
  • Yes
Here you may provide further details
FR
il existe des laboratoires de biotechnologie compétents qui peuvent detecter les OGM.
Survey 26. How many laboratories in your country are certified for LMO detection?
indicator 2.3.3
  • None
Survey 27. How many of the certified laboratories in the previous question are operational?
indicator 2.3.4
  • None
Survey 28. Has your country received any financial and/or technical assistance for capacity-building in the area of liability and redress relating to living modified organisms?
indicator 2.4.1
  • Yes
Here you may provide further details
FR
Des assistances techniques ont été apportées par des organisations sous régionales pour une meilleure compréhension des questions de responsabilité et la réparation relative au OGM.
Survey 29. Does your country have administrative or legal instrument that provide for response measures for damage to biodiversity resulting from living modified organisms?
indicator 2.4.2
  • Yes
Here you may provide further details
FR
La loi portant régime de sécurité en matière de biotechnologie prend en compte les aspects de responsabilité et de réparation.
Survey 30. Has your country informed the public about existing modalities for public participation in the decision-making process regarding living modified organisms?
indicator 2.5.2
  • Yes
Here you may provide further details
FR
Au niveau du Burkina, il existe un Observatoire National de Biosécurité constitué de diverses sensibilités représentant les structures publiques et la société civile. Cet Observatoire est toujours saisi avant une prise de décision.
Survey 31. If you answered yes to the previous question, please indicate the modalities used to inform the public?
indicator 2.5.2
  • National website
  • Public hearings
  • conférences de presse avec la télévision, les radios nationales et les presses écrites
Survey 32. If you indicated multiple modalities for public participation in the question above, which one was most used?
indicator 2.5.2
  • Public hearings
Survey 33. How many academic institutions in your country are offering biosafety education and training courses and programmes?
indicator 2.7.1
  • One or more
Here you may provide further details
FR
Des modules de formation en biosécurité sont dispensées dans deux universités du pays.
Survey 34. How many biosafety training materials and/or online modules are available in your country?
indicator 2.7.2
  • None
Survey 35. Does your country have in place a monitoring and/or an enforcement system?
indicator 3.1.6
Survey 35.a) Monitoring system
  • No
Survey 35.b) Enforcement system
  • No
Survey 36. Please indicate the number of regional, national and international events organized in relation to biosafety (e.g. seminars, workshops, press conferences, educational events, etc.,) in the last 2 years.
indicator 4.3.1
  • 25 or more
Here you may provide further details
FR
Notre pays a participé à des évènements (séminaires et ateliers) internationaux et régionaux ou l'expérience du Burkina faso en matière de communication a été partagée.  Aussi au niveau national, des ateliers, des conférences de presse, des visites guidées, des expositions, des évènements éducatifs et une pièce de théâtre sur les OGM ont été réalisés.
Survey 37. Please indicate the number of biosafety related publications that has been made available in your country in the last year.
indicator 4.3.2
  • One or more
Survey 38. If biosafety related publications were made available (see question above), please indicate which modalities were preferred.
indicator 4.3.2
  • distribution au cours des activités de sensibilisation
Survey 39. How many collaborative initiatives (including joint activities) on the Cartagena Protocol and other Conventions and processes has your government established in the last 4 years?
indicator 5.2.1
  • None
Survey 40. Does your country have any awareness and outreach programmes on biosafety?
indicator 5.3.1
  • Yes
Here you may provide further details
FR
Des activités de sensibilisations sont programmées et réalisées à travers le pays.
Survey 41. If you answered yes to the question above, please indicate what entity is responsible for carrying out the programmes and/or services and at which level the programmes take place.
indicator 5.3.1
E.g. local, national, etc.,
FR
L'Agence nationale de biosécurité est responsable de la mise en oeuvre de ces activités de sensibilisation. Cependant, d'autres structures font quelques activités de sensibilisation. Certaines activités sont menées au niveau national et d'autres au niveau local.
Survey 42. Has your country designed and/or implemented an outreach/communication strategy on biosafety?
indicator 5.3.2
  • Yes
Here you may provide further details
FR
Une stratégie de communication est entrain d'être exécutée depuis 2009. cette stratégie est basée sur l'approche par groupe cible:   Pour certains groupes cible, un nombre élevé de personnes ont été sensibilisé:  Décideurs politique et parlementaires; checheurs et enseignants, large public dans les régions (3305 personnes); agents d'encadrement des producteurs (544 personnes); les communicateurs; élèves et étudiants (7750 personnes); leadeurs d'opinion; les agents aux frontières; etc.
Survey 43. Please indicate the number of educational materials on biosafety that are available and accessible to the public.
indicator 5.3.4
  • One or more
Here you may provide further details
FR
Pièce théâtrale, dépliants, supports de communication, posters sont disponibles et accéssibles au public.